Cargando…
Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
Tacrolimus is the mainstay of immunosuppression in liver transplantation to prevent rejection. However, the clinical use of tacrolimus is complicated by its narrow therapeutic window and significant intra-patient variability (IPV). High tacrolimus IPV is associated with overexposure and adverse effe...
Autores principales: | Kim, Hyun Jeong, Lee, Juhan, Lee, Jae Geun, Joo, Dong Jin, Kim, Myoung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519914/ https://www.ncbi.nlm.nih.gov/pubmed/36171260 http://dx.doi.org/10.1038/s41598-022-20636-3 |
Ejemplares similares
-
Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk
por: Kim, Eun Jin, et al.
Publicado: (2021) -
Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
por: Kim, Deok-Gie, et al.
Publicado: (2023) -
Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
por: Kim, Deok Gie, et al.
Publicado: (2022) -
Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019) -
Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation
por: Morais, Maria Clara, et al.
Publicado: (2023)